Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

被引：0
|
作者：
Edoardo Caronna
Victor José Gallardo
Alicia Alpuente
Marta Torres-Ferrus
Patricia Pozo-Rosich
机构：
[1] Universitat Autònoma de Barcelona,Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine
[2] Universitat Autònoma de Barcelona,Headache and Neurological Pain Research Group, Vall d’Hebron Research Institute, Department of Medicine
来源：
The Journal of Headache and Pain | 2021年 / 22卷
关键词：
Migraine; Medication overuse; CGRP; Monoclonal antibodies; Erenumab; Galcanezumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
  • [42] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
  • [43] Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
    Pellesi, Lanfranco
    Guerzoni, Simona
    Pini, Luigi Alberto
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (06): : 534 - 547
  • [44] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
    di Cola, Francesca Schiano
    Ceccardi, Giulia
    Caratozzolo, Salvatore
    Bolchini, Marco
    Di Pasquale, Michele
    Rao, Renata
    Padovani, Alessandro
    CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
  • [45] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [46] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Lovati, Carlo
    Bernasconi, Gianna
    Capogrosso, Chiara
    Molteni, Laura
    Giorgetti, Federica
    Dell'Osso, Bernardo
    Pantoni, Leonardo
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767
  • [47] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Carlo Lovati
    Gianna Bernasconi
    Chiara Capogrosso
    Laura Molteni
    Federica Giorgetti
    Bernardo Dell’Osso
    Leonardo Pantoni
    Neurological Sciences, 2022, 43 : 5765 - 5767
  • [48] Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
    Piero Barbanti
    Gabriella Egeo
    Cinzia Aurilia
    Claudia Altamura
    Florindo d’Onofrio
    Cinzia Finocchi
    Maria Albanese
    Marco Aguggia
    Renata Rao
    Maurizio Zucco
    Fabio Frediani
    Massimo Filippi
    Roberta Messina
    Sabina Cevoli
    Antonio Carnevale
    Giulia Fiorentini
    Stefano Messina
    Francesco Bono
    Paola Torelli
    Stefania Proietti
    Stefano Bonassi
    Fabrizio Vernieri
    The Journal of Headache and Pain, 2022, 23
  • [49] Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
    Barbanti, Piero
    Egeo, Gabriella
    Aurilia, Cinzia
    Altamura, Claudia
    D'Onofrio, Florindo
    Finocchi, Cinzia
    Albanese, Maria
    Aguggia, Marco
    Rao, Renata
    Zucco, Maurizio
    Frediani, Fabio
    Filippi, Massimo
    Messina, Roberta
    Cevoli, Sabina
    Carnevale, Antonio
    Fiorentini, Giulia
    Messina, Stefano
    Bono, Francesco
    Torelli, Paola
    Proietti, Stefania
    Bonassi, Stefano
    Vernieri, Fabrizio
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [50] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, Amira
    Najjar, Atia
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
12345